Synthetic Studies of Imidazole C-nucleosides aimed at Novel Histomine Ligands
Synthetic Studies of Imidazole C-nucleosides aimed at Novel Histomine Ligands
批准号:
08672462
负责人:
KURIHARA Takushi
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
我们最近报道了C-4连接的咪唑核苷的β-立体选择性合成,在已有的基础上,我们开始有兴趣合成咪唑C-核苷(ICN)类似物的四个可能的立体异构体,其中咪唑和氨基被限制在四氢呋喃环上。首次提出了一条合成新型2‘,3’-二脱氧咪唑C-核苷衍生物四种可能的立体异构体的路线,该路线是通过利用L-谷氨酸中的PHSE基团来实现的。以较高的产率将关键中间体硒内酯相继衍生为5-芳基-2‘,3’-二脱氧-ICN衍生物,它们的对映体通过D-戊二酸的核苷以相同的方法提供。5‘-氨基-2’,3‘-二氢-2’,3‘-二脱氧-ICN的四个异构体也是通过氧化消除中间体的C2’-苯基亚硒基而合成的。以D-核糖为起始原料,合成了4(5)-(5-氨基甲基呋喃-2-基)-1H-咪唑(5)。特别值得注意的是,只有名为咪呋拉明的(+)-4(5)-{(2R,5R)-5-(aminomethyl)-tetrahydrofuran-2-yl}imidazole被活体脑微透析鉴定为H3激动剂。
英文摘要
We recently reported the beta-stereoselective synthesis of C-4 linked imidazole nucleosides, On the basis of what we have now, we became interested in the synthesis of the four possible stereoisomerers of a novel imidazole C-nucleoside (ICN) analogues in which the imidazole and amino groups were restricted across a tetrahydrofuran ring. A synthetic route to the four possible stereoisomers of a novel 2' 3' dideoxyimidazole C-nucleoside derivative was at first developed via the efficient use of PhSe group from L-glutamic acid. The key intermediates selenolactols were successively derived to the respective 5 arnino-2', 3' -dideoxy-ICN derivatives in excellent yields Their enantiomers were provided via nucleosides from D-glutarnic acid by the same methodology. The four isomers of 5' Amino-2', 3' didehydro-2' 3' dideoxy-ICN were also synthesized via oxidative elimination the C2'-phenylselenyl group of the intermediates. Further, 4(5)-(5-aminomethylfuran-2-yl)-1H-imidazole (5) was synthesized starting from D-ribose. Of particular interest, only (+)-4(5)-{(2R,5R)-5-(aminomethyl)-tetrahydrofuran-2-yl}imidazole named imifuramine, was identified as a H_3 agonist by in vivo brain microdialysis.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
S.Harusawa: "Synthesis of Imifuramine and Its Stereoisomers Exhibiting Histamine H_3-Agonistic Activity" Tetrahedron Letters. 55・in press. (1999)
S.Harusawa:“具有组胺 H_3 激动活性的咪呋胺及其立体体的合成”,《四面体快报》55·出版(1999 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Harusawa: "Efficient and β-Stereoselective Synthesis of 4(5)-(β-D-Ribofuranosyl)- and 4(5)-(2-Deoxyribofuranosyl)imidazoles." J.Org.Chem.61・13. 4405-4411 (1996)
S.Harusawa:“4(5)-(β-D-呋喃核糖基)-和 4(5)-(2-脱氧呋喃核糖基)咪唑的高效和 β-立体选择性合成。J.Org.Chem.61・13。” -4411 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Harusawa: "Stereoselective Synthesis of the C-4 Linked Imidazole Nucleosides Using Modified Mitsunobu Reaction." Tetrahedron Letters. 36・18. 3165-3168 (1995)
S.Harusawa:“利用改进的 Mitsunobu 反应立体选择性合成 C-4 连接的咪唑核苷”36・18(1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Harusawa: "Efficient and beta-Stereoselective Synthesis of 4(5)-Methy1-5(4)-(5-amino-5-deoxy-beta-D-ribofuranosy1)imidazole and Related Compounds Exhibiting Antiulcer Activity" Chem.Pharm.Bull.45. 53-61 (1997)
S.Harusawa:“高效、β-立体选择性合成 4(5)-Methy1-5(4)-(5-amino-5-deoxy-beta-D-ribofuranosy1)imidillo 及相关化合物表现出抗溃疡活性” Chem.Pharm
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Harusawa: "Efficient and β-Stereoselective Synthesis of 4(5)-(β-D-Ribofuranosyl)-and 4(5)-(2-Deoxyribofuranosyl) Imidazoles." J. Org. Chem.16・13. 4405-4411 (1996)
S. Harusawa:“4(5)-(β-D-呋喃核糖基)-和 4(5)-(2-脱氧呋喃核糖基)咪唑的高效和 β-立体选择性合成”J. Org. 4405。 -4411 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Development and Application of Novel Histamine H_3 agonist Imifuramine
-
批准号:11672127
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1999
-
负责人:KURIHARA Takushi
-
依托单位:
Studies on Synthesis and Biological Activities of Carbaeudistomins having Specific Anti viral Activities
-
批准号:06672128
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.32万
-
财政年份:1994
-
负责人:KURIHARA Takushi
-
依托单位:
Antiviral Structure-Activity Studies on Marine Natural Product Eudistomin Related Compounds
-
批准号:03671021
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1991
-
负责人:KURIHARA Takushi
-
依托单位:
海外基金